RIDA: A promising 14.5 kDa translational inhibitor protein as a drug target or biomarker

Target Name: RIDA

NCBI ID: G10247

RIDA: A promising 14.5 kDa translational inhibitor protein as a drug target or biomarker

Abstract:
RIDA (RIDA1-like protein) is a 14.5 kDa transmembrane protein that has been identified as a potential drug target or biomarker. It is expressed in various tissues and has been shown to play a critical role in various cellular processes. In this article, we will discuss the properties of RIDA, its potential drug target or biomarker status, and the current research on this protein.

Introduction:
RIDA (RIDA1-like protein) is a 14.5 kDa transmembrane protein that is expressed in various tissues, including brain, heart, and liver. It is characterized by a N-terminal extracellular domain, a transmembrane region, and a C-terminal intracellular domain. RIDA has been shown to play a critical role in various cellular processes, including cell signaling, cell adhesion, and cell survival.

Properties of RIDA:
RIDA is a protein that is primarily localized to the endoplasmic reticulum (ER) and has been shown to interact with various cellular signaling pathways. It has been shown to play a critical role in the PI3K/Akt signaling pathway, which is involved in various cellular processes, including cell signaling, cell adhesion, and cell survival.

Potential drug target or biomarker status:
RIDA is a protein that has been shown to interact with various drug targets, including inhibitors of the PI3K/Akt signaling pathway. This suggests that RIDA may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Current research on RIDA:
Currently, there is limited research on RIDA, and there are no known drugs that are specifically designed to target RIDA. However, research is being conducted to investigate the potential drug targets and biomarkers for RIDA.

Conclusion:
In conclusion, RIDA is a 14.5 kDa transmembrane protein that has been identified as a potential drug target or biomarker. Its properties, including its interaction with various cellular signaling pathways, suggest that it may be a promising target for various diseases. Further research is needed to investigate the potential drug targets and biomarkers for RIDA.

Protein Name: Reactive Intermediate Imine Deaminase A Homolog

Functions: Catalyzes the hydrolytic deamination of enamine/imine intermediates that form during the course of normal metabolism. May facilitate the release of ammonia from these potentially toxic reactive metabolites, reducing their impact on cellular components. It may act on enamine/imine intermediates formed by several types of pyridoxal-5'-phosphate-dependent dehydratases including L-threonine dehydratase

More Common Targets